The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of onvansertib in combination with abiraterone and prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC).
 
David Johnson Einstein
Honoraria - OncLive
Research Funding - Bristol-Myers Squibb (Inst); Cardiff Oncology (Inst); Foundation Medicine (Inst); Puma Biotechnology (Inst)
 
Atish Dipankar Choudhury
Employment - LeMaitre Vascular (I)
Honoraria - Aptitude Health; Bayer; Journal of Clinical Pathways/Oncology Learning Network; OncLive; Targeted Oncology
Consulting or Advisory Role - Bayer; Clovis Oncology; Dendreon; Lilly; MedaCorp
Research Funding - Bayer; Janssen (Inst)
Travel, Accommodations, Expenses - Genentech
 
Philip James Saylor
(OPTIONAL) Uncompensated Relationships - Bayer (Inst)
 
Jesse Christopher Patterson
Employment - Foghorn Therapeutics (I)
Stock and Other Ownership Interests - Constellation Pharmaceuticals (I)
Research Funding - Cardiff Oncology
Patents, Royalties, Other Intellectual Property - PLK1i + abiraterone, licensed by Cardiff
 
Peter Croucher
Employment - Cardiff Oncology
Stock and Other Ownership Interests - Cardiff Oncology
 
Maya Ridinger
Employment - Cardiff Oncology
Stock and Other Ownership Interests - Cardiff Oncology
Travel, Accommodations, Expenses - Cardiff Oncology
 
Mark G. Erlander
Employment - Cardiff Oncology
Leadership - Cardiff Oncology
Stock and Other Ownership Interests - Cardiff Oncology
 
Michael B. Yaffe
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - Applied BioMath
Research Funding - Cardiff Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Coagulation/fibrinolysis diagnostics and therapeutic fibrinolytics
(OPTIONAL) Uncompensated Relationships - Cardiff Oncology
 
Glenn Bubley
No Relationships to Disclose